Shingrix
- Product NDC
- 58160-849
- 11-digit product format
- 581600849
- Labeler code
- 58160
- Product ID
- 58160-849_e8a2f0fb-062a-4adc-ac30-f378fbcf87ed
- Type
- VACCINE
- Nonproprietary name
- Zoster Vaccine Recombinant, Adjuvanted
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Labeler
- GlaxoSmithKline Biologicals SA
- Application
- BLA125614
- Marketing category
- BLA
- Marketing start
- 2025-07-16
- Substance
- RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN
- Active strength
- 50 ug/.5mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 58160-849-52 | 58160084952 | 10 SYRINGE in 1 CARTON (58160-849-52) / .5 mL in 1 SYRINGE (58160-849-43) | 10 syringe | 2025-07-16 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Shingrix | A-S Medication Solutions | 2026-03-06 | VACCINE LABEL | 1 |
| Shingrix | GlaxoSmithKline Biologicals SA | 2026-02-13 | VACCINE LABEL | 23 |
| Shingrix | GlaxoSmithKline Biologicals SA | 2025-07-16 | VACCINE LABEL | 21 |